Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children
Clicks: 454
ID: 112629
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
79.8
/100
454 views
300 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 10 articles by views in current opinion in infectious diseases
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The appearance of CA-MRSA has important implications for therapy of infections caused by S. aureus in children. Three specific issues are the development of resistance during clindamycin therapy, insufficient data on the use of trimethoprim-sulfamethoxazole in serious CA-MRSA infections, and the app …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (42 words).
Try re-searching for a better abstract.
| Reference Key |
jf2003currenttreatment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Marcinak JF;Frank AL;; |
| Journal | current opinion in infectious diseases |
| Year | 2003 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
aged
Child
Infant
risk factors
80 and over
anti-bacterial agents / therapeutic use
drug resistance
community-acquired infections / epidemiology
methicillin resistance*
microbial
staphylococcus aureus / drug effects*
staphylococcal infections / epidemiology
staphylococcus aureus / genetics
anti-bacterial agents / classification
staphylococcus aureus / pathogenicity
pmid:12821819
doi:10.1097/00001432-200306000-00014
john f marcinak
arthur l frank
community-acquired infections / drug therapy*
staphylococcal infections / drug therapy*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.